Rapid determination of plasma vigabatrin by LC-ESI-MS/MS supporting therapeutic drug monitoring for children with infantile spasms
Jie Wang,Yuan-Yuan Zhang,Hong-Li Guo,Xiao-Peng Lu,Feng Chen,Shan-shan Wang,Chunfeng Wu,Yahui Hu
DOI: https://doi.org/10.1039/d2ay02017c
IF: 3.1
2023-02-12
Analytical Methods
Abstract:Vigabatrin is one of the second-generation anti-seizure medications (ASMs) designated orphan drug by the FDA for monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age. Vigabatrin is also indicated as adjunctive therapy for adults and pediatric patients 10 years of age and older with refractory complex partial seizures. Ideally, the vigabatrin treatment entails achieving complete seizure freedom without significant adverse effects, and the therapeutic drug monitoring (TDM) will make a significant contribution to this aim, which provides a pragmatic approach to such epilepsy care in that the dose tailoring can be undertaken for uncontrollable seizures and in cases of clinical toxicity guided by the drug concentrations. Thus, reliable assays are mandatory for TDM to be valuable and blood, plasma or serum are the matrixes of choice. In this study, a simple, rapid, and sensitive LC-ESI-MS/MS method for the measurement of plasma vigabatrin was developed and validated. The sample clean-up was performed by an easy-to-use method, i.e., protein precipitation by acetonitrile (ACN). Chromatographic separation of vigabatrin and vigabatrin-13C,d2 (internal standard) was achieved on the Waters Symmetry C18 column (4.6 mm × 50 mm, 3.5 μm) with an isocratic elution at a flow rate of 0.35 mL/min. The target analyte was completely separated by elution with high water equality for 5 min, without any endogenous interference. The method showed good linearity over the 0.010–50.0 μg/mL concentration range with a correlation coefficient r2 ≥ 0.9980. The intra-batch and inter-batch precision and accuracy, recovery, and stability of method were all within the acceptable criteria. Moreover, the method was successfully used for pediatric patients treated with vigabatrin and also provided valuable information for clinicians by monitoring plasma vigabatrin level in our hospital.
spectroscopy,chemistry, analytical,food science & technology